K. Moriyama

1.3k total citations
23 papers, 257 citations indexed

About

K. Moriyama is a scholar working on Molecular Biology, Infectious Diseases and Pharmaceutical Science. According to data from OpenAlex, K. Moriyama has authored 23 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Infectious Diseases and 6 papers in Pharmaceutical Science. Recurrent topics in K. Moriyama's work include DNA and Nucleic Acid Chemistry (7 papers), HIV/AIDS drug development and treatment (7 papers) and Drug Solubulity and Delivery Systems (5 papers). K. Moriyama is often cited by papers focused on DNA and Nucleic Acid Chemistry (7 papers), HIV/AIDS drug development and treatment (7 papers) and Drug Solubulity and Delivery Systems (5 papers). K. Moriyama collaborates with scholars based in Japan, United Kingdom and United States. K. Moriyama's co-authors include Ichiro Hirao, Michiko Kimoto, Shigeyuki Yokoyama, Kazuo Negishi, Takeki Mitsui, David Loakes, Tetsuya Suzuki, David M. Williams, Kazuno Negishi and D. M. Brown and has published in prestigious journals such as Nucleic Acids Research, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.

In The Last Decade

K. Moriyama

23 papers receiving 252 citations

Peers

K. Moriyama

GENET

Tomasz Ratajczak Poland

Beata Wielgus‐Kutrowska Poland

Esben Trabjerg Denmark

Christian Schütz Germany

Kelly K. Arthur United States

C.L. Barnes United Kingdom

Thomas Uhlig France

Anna Modrak‐Wójcik Poland

M. Janecek United Kingdom

Sergei Grokhovsky Russia

Tomasz Ratajczak Poland

K. Moriyama

341 ×2.1

75 ×2.0

27 ×0.8

32 ×1.3

22 ×1.0

GENET

Citations per year, relative to K. Moriyama K. Moriyama (= 1×) peers Tomasz Ratajczak

Countries citing papers authored by K. Moriyama

Since Specialization

Citations

This map shows the geographic impact of K. Moriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Moriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Moriyama more than expected).

Fields of papers citing papers by K. Moriyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Moriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Moriyama. The network helps show where K. Moriyama may publish in the future.

Co-authorship network of co-authors of K. Moriyama

This figure shows the co-authorship network connecting the top 25 collaborators of K. Moriyama. A scholar is included among the top collaborators of K. Moriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Moriyama. K. Moriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsuo, Kazuhiro, K. Moriyama, Tatsuro Yamamoto, et al.. (2021). Risk factors for clozapine-induced central nervous system abnormalities in Japanese patients with treatment-resistant schizophrenia. Asian Journal of Psychiatry. 60. 102652–102652. 5 indexed citations

Moriyama, K., et al.. (2018). Fluorescence-Based High-Throughput Salt Screening. Journal of Pharmaceutical Sciences. 107(7). 1870–1878. 3 indexed citations

Moriyama, K., et al.. (2017). Visualization of Protonation/Deprotonation of Active Pharmaceutical Ingredient in Solid State by Vapor Phase Amine-Selective Alkyne Tagging and Raman Imaging. Journal of Pharmaceutical Sciences. 106(7). 1778–1785. 5 indexed citations

Moriyama, K.. (2016). Advanced Applications of Raman Imaging for Deeper Understanding and Better Quality Control of Formulations. Current Pharmaceutical Design. 22(32). 4912–4916. 9 indexed citations

Moriyama, K., et al.. (2016). Assessment of drug content uniformity of atropine sulfate triturate by liquid chromatography–tandem mass spectrometry, X-ray powder diffraction, and Raman chemical imaging. Journal of Pharmaceutical Health Care and Sciences. 2(1). 4–4. 5 indexed citations

Sasaki, Hiroaki, et al.. (2015). Vapor Phase Alkyne Coating of Pharmaceutical Excipients: Discrimination Enhancement of Raman Chemical Imaging for Tablets. Journal of Pharmaceutical Sciences. 104(12). 4093–4098. 11 indexed citations

Takami, Yoichiro, K. Moriyama, Yuka Inoue, et al.. (2015). Prevention of the exposure by cyclophosphamide oral tablet. Journal of Pharmaceutical Health Care and Sciences. 1(1). 20–20. 5 indexed citations

Moriyama, K., et al.. (2015). Crystal face identification by Raman microscopy for assessment of crystal habit of a drug. International Journal of Pharmaceutics. 480(1-2). 101–106. 12 indexed citations

Moriyama, K., et al.. (2015). Visualization of Primary Particles in a Tablet Based on Raman Crystal Orientation Mapping. Pharmaceutica Analytica Acta. 6(12). 4 indexed citations

10.

Hayatsu, Hikoya, Kazuo Negishi, Mie Shiraishi, Kaoru Tsuji, & K. Moriyama. (2007). Chemistry of Bisulfite Genomic Sequencing; Advances and Issues. Nucleic Acids Symposium Series. 51(1). 47–48. 3 indexed citations

11.

Moriyama, K., Tetsuya Suzuki, Kazuo Negishi, et al.. (2007). Effects of Introduction of Hydrophobic Group on Ribavirin Base on Mutation Induction and Anti-RNA Viral Activity. Journal of Medicinal Chemistry. 51(1). 159–166. 25 indexed citations

12.

Kimoto, Michiko, K. Moriyama, Shigeyuki Yokoyama, & Ichiro Hirao. (2007). Cytostatic evaluations of nucleoside analogs related to unnatural base pairs for a genetic expansion system. Bioorganic & Medicinal Chemistry Letters. 17(20). 5582–5585. 15 indexed citations

13.

Suzuki, Tetsuya, et al.. (2006). Template properties of mutagenic cytosine analogues in reverse transcription. Nucleic Acids Research. 34(22). 6438–6449. 14 indexed citations

14.

Suzuki, Tetsuya, et al.. (2005). Mutagenic properties of ribonucleotide analogues in reverse transcription with HIV and AMV reverse transcriptases. Nucleic Acids Symposium Series. 49(1). 97–98. 1 indexed citations

15.

Moriyama, K., Michiko Kimoto, Takeki Mitsui, Shigeyuki Yokoyama, & Ichiro Hirao. (2005). Site-specific biotinylation of RNA molecules by transcription using unnatural base pairs. Nucleic Acids Research. 33(15). e129–e129. 52 indexed citations

16.

Kobayashi, Keita, K. Moriyama, Shigenori Iwai, et al.. (2002). Use of yeast transformation by oligonucleotides to study DNA lesion bypass in vivo. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 502(1-2). 53–60. 20 indexed citations

17.

Moriyama, K., et al.. (2001). HIGHLY EFFICIENT RANDOM MUTAGENESIS IN TRANSCRIPTION-REVERSE-TRANSCRIPTION CYCLES BY A HYDROGEN BOND AMBIVALENT NUCLEOSIDE 5′-TRIPHOSPHATE ANALOGUE: POTENTIAL CANDIDATES FOR A SELECTIVE ANTI-RETROVIRAL THERAPY. Nucleosides Nucleotides & Nucleic Acids. 20(8). 1473–1483. 11 indexed citations

18.

Moriyama, K., Yoshiaki Kikkawa, David Loakes, & Kazuo Negishi. (1999). Disturbance of genetic information by a ribonucleotide analogue. Nucleic Acids Symposium Series. 42(1). 131–132. 1 indexed citations

19.

Moriyama, K.. (1998). Synthesis and RNA polymerase incorporation of the degenerate ribonucleotide analogue rPTP. Nucleic Acids Research. 26(9). 2105–2111. 8 indexed citations

20.

Negishi, Kazuno, et al.. (1997). The Mechanism of Mutation Induction by a Hydrogen Bond Ambivalent, Bicyclic N4-oxy-2'-deoxycytidine in Escherichia coli. Nucleic Acids Research. 25(8). 1548–1552. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact